SLV313 is a dopamine D2 receptor antagonist and serotonin 5-HT1A receptor agonist: In vitro and in vivo neuropharmacology

Autor:	C.G. Kruse, Jeffrey C. Glennon, Long Stephen K, B.J. Van Vliet, Andrew C. McCreary, R. Siarey, Mayke B. Hesselink, Eric Ronken, R W Feenstra
Rok vydání:	2002
Předmět:	Pharmacology Agonist medicine.drug_class Chemistry Psychiatry and Mental health Dopamine receptor D1 Neurology Dopamine receptor D3 Dopamine receptor D2 medicine 5-HT6 receptor 5-HT1A receptor Inverse agonist Pharmacology (medical) Neurology (clinical) Biological Psychiatry Endogenous agonist
Zdroj:	ResearcherID
ISSN:	0924-977X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f5300b3586a59e2eb233baa33d60956 https://doi.org/10.1016/s0924-977x(02)80381-9 Zobrazit plný text záznamu Full Text from ScienceDirect